BioRestorative Therapies (BRTX) Short Interest Ratio & Short Volume $1.80 -0.17 (-8.42%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$1.80 0.00 (0.00%) As of 02/21/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends BioRestorative Therapies Short Interest DataBioRestorative Therapies (BRTX) has a short interest of 235,600 shares, representing 4.64% of the float (the number of shares available for trading by the public). This marks a 80.95% increase in short interest from the previous month. The short interest ratio (days to cover) is 3.3, indicating that it would take 3.3 days of the average trading volume of 508,939 shares to cover all short positions.Current Short Interest235,600 sharesPrevious Short Interest130,200 sharesChange Vs. Previous Month+80.95%Dollar Volume Sold Short$560,728.00Short Interest Ratio3.3 Days to CoverLast Record DateJanuary 31, 2025Outstanding Shares6,920,000 sharesFloat Size5,080,000 sharesShort Percent of Float4.64%Today's Trading Volume392,210 sharesAverage Trading Volume508,939 sharesToday's Volume Vs. Average77% Short Selling BioRestorative Therapies? Sign up to receive the latest short interest report for BioRestorative Therapies and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBRTX Short Interest Over TimeBRTX Days to Cover Over TimeBRTX Percentage of Float Shorted Over Time BioRestorative Therapies Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/2025235,600 shares $560,728.00 +81.0%4.6%3.3 $2.38 1/15/2025130,200 shares $234,360.00 +19.5%2.6%2 $1.80 12/31/2024109,000 shares $155,870.00 -28.9%2.2%2.1 $1.43 12/15/2024153,400 shares $222,430.00 +129.3%3.0%3.2 $1.45 11/30/202466,900 shares $102,357.00 -10.1%1.3%1.3 $1.53 11/15/202474,400 shares $109,368.00 +68.3%1.5%2.9 $1.47 10/31/202444,200 shares $68,952.00 -4.3%0.9%1.7 $1.56 10/15/202446,200 shares $79,926.00 -8.2%0.9%1.9 $1.73 9/30/202450,300 shares $87,522.00 -13.9%1.0%1.7 $1.74 9/15/202458,400 shares $98,696.00 +13.4%1.2%1 $1.69 Get the Latest News and Ratings for BRTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioRestorative Therapies and its competitors with MarketBeat's FREE daily newsletter. 8/31/202451,500 shares $84,460.00 -15.3%1.0%0 $1.64 8/15/202460,800 shares $100,320.00 -17.4%1.2%0 $1.65 7/31/202473,600 shares $112,608.00 -48.9%1.3%0 $1.53 7/15/2024144,000 shares $254,880.00 -46.4%2.6%0.1 $1.77 6/30/2024268,800 shares $545,664.00 -85.6%4.9%0.1 $2.03 6/15/20241,870,000 shares $3.46 million +2,211.5%34.0%0.9 $1.85 5/31/202480,900 shares $101,125.00 -39.0%1.5%0.2 $1.25 5/15/2024132,600 shares $181,662.00 -21.8%2.4%0.2 $1.37 4/30/2024169,600 shares $240,832.00 +322.9%3.5%0.3 $1.42 4/15/202440,100 shares $52,130.00 -1.0%0.8%0.1 $1.30 3/31/202440,500 shares $55,890.00 +103.5%0.8%0.1 $1.38 3/15/202419,900 shares $26,467.00 +197.0%0.6%0 $1.33 2/29/20246,700 shares $9,380.00 -90.9%0.2%0 $1.40 2/15/202473,500 shares $108,045.00 +260.3%2.1%0.2 $1.47 1/31/202420,400 shares $33,252.00 +121.7%0.6%0.1 $1.63 1/15/20249,200 shares $14,720.00 -48.9%0.3%0.6 $1.60 12/31/202318,000 shares $31,318.20 -52.1%0.5%1.1 $1.74 12/15/202337,600 shares $71,440.00 +64.2%1.0%1.9 $1.90 11/30/202322,900 shares $43,968.00 -26.1%0.6%0.7 $1.92 11/15/202331,000 shares $56,575.00 -33.6%0.8%0.9 $1.83 10/31/202346,700 shares $92,466.00 -30.3%1.3%1.3 $1.98 10/15/202367,000 shares $148,070.00 -5.1%1.8%1.6 $2.21 9/30/202370,600 shares $126,374.00 +256.6%1.9%1.1 $1.79 9/15/202319,800 shares $33,066.00 -19.8%0.5%0.2 $1.67 8/31/202324,700 shares $54,340.00 -30.0%0.7%0.3 $2.20 8/15/202335,300 shares $0.00 -47.3%1.0%0.5 $0.00 BRTX Short Interest - Frequently Asked Questions What is BioRestorative Therapies' current short interest? Short interest is the volume of BioRestorative Therapies shares that have been sold short but have not yet been covered or closed out. As of January 31st, traders have sold 235,600 shares of BRTX short. 4.64% of BioRestorative Therapies' shares are currently sold short. Learn More on BioRestorative Therapies' current short interest. What is a good short interest ratio for BioRestorative Therapies? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BRTX shares currently have a short interest ratio of 3.0. Learn More on BioRestorative Therapies's short interest ratio. What is a good short interest percentage for BioRestorative Therapies? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.64% of BioRestorative Therapies' floating shares are currently sold short. Is BioRestorative Therapies' short interest increasing or decreasing? BioRestorative Therapies saw a increase in short interest in January. As of January 31st, there was short interest totaling 235,600 shares, an increase of 81.0% from the previous total of 130,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is BioRestorative Therapies' float size? BioRestorative Therapies currently has issued a total of 6,920,000 shares. Some of BioRestorative Therapies' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. BioRestorative Therapies currently has a public float of 5,080,000 shares. How does BioRestorative Therapies' short interest compare to its competitors? 4.64% of BioRestorative Therapies' shares are currently sold short. Here is how the short interest of companies in the industry of "healthcare" compare to BioRestorative Therapies: Burning Rock Biotech Limited (0.68%), Enzo Biochem, Inc. (0.79%), Concord Medical Services Holdings Limited (0.19%), Mangoceuticals, Inc. (3.06%), OpGen, Inc. (0.19%), Kindly MD, Inc. (2.50%), Ontrak, Inc. (2.50%), BioNexus Gene Lab Corp. (2.68%), Vsee Health, Inc. (1.84%), ATI Physical Therapy, Inc. (5.31%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks. What does it mean to sell short BioRestorative Therapies stock? Short selling BRTX is an investing strategy that aims to generate trading profit from BioRestorative Therapies as its price is falling. BRTX shares are trading down $0.17 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against BioRestorative Therapies? A short squeeze for BioRestorative Therapies occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BRTX, which in turn drives the price of the stock up even further. How often is BioRestorative Therapies' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BRTX, twice per month. The most recent reporting period available is January, 31 2025. More Short Interest Resources from MarketBeat Related Companies Burning Rock Biotech Short Interest Data Enzo Biochem Short Interest Data Concord Medical Services Short Interest Data Mangoceuticals Short Interest Data OpGen Short Interest Data Kindly MD Short Interest Data Ontrak Short Interest Data BioNexus Gene Lab Short Interest Data Vsee Health Short Interest Data ATI Physical Therapy Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BRTX) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioRestorative Therapies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioRestorative Therapies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.